Patent Assignment
Reel/Frame 039861/0428
Assignment of Assignor's Interest
Recorded: 2016-08-29
Pages: 32
Assignors
BAYEVER, ELIEL
Executed: 2016-08-22
DHINDSA, NAVREET
Executed: 2016-08-19
FITZGERALD, JONATHAN BASIL
Executed: 2016-08-17
LAIVINS, PETER
Executed: 2016-08-18
MOYO, VICTOR
Executed: 2016-08-18
NIYIKIZA, CLET
Executed: 2016-08-18
KIM, JAEYEON
Executed: 2016-08-24
Assignee
MERRIMACK PHARMACEUTICALS, INC.
ONE KENDALL SQUARE, SUITE B7201, CAMBRIDGE, MASSACHUSETTS, 02139
Covered Properties
(5)
Treatment of Pancreatic Cancer with Liposomal Irinotecan
Application:
62/278,751 →
Treatment of Pancreatic Cancer with Liposomal Irinotecan
Application:
62/281,458 →
Treatment of Pancreatic Cancer with Liposomal Irinotecan
Application:
62/328,830 →
Treatment of Pancreatic Cancer with Liposomal Irinotecan
Application:
62/341,223 →
Treatment of Pancreatic Cancer with Liposomal Irinotecan
Application:
62/355,640 →
Related Assignments
(3)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Apr 27, 2016
From: BAYEVER, ELIEL; DHINDSA, NAVREET; FITZGERALD, JONATHAN BASIL; LAIVINS, PETER N.
To: MERRIMACK PHARMACEUTICALS, INC.
Reel/Frame 038397/0037 →
Assignment of Assignor's Interest
May 1, 2017
From: MERRIMACK PHARMACEUTICALS, INC.
To: IPSEN BIOPHARM LTD.
Reel/Frame 042377/0696 →
Change of Address of Assignee
May 17, 2017
From: MERRIMACK PHARMACEUTICALS, INC.
To: IPSEN BIOPHARM LTD.
Reel/Frame 042522/0334 →